110 related articles for article (PubMed ID: 12465176)
1. Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis.
Casari S; Haeney M; Farrand S; Herrick A
J Rheumatol; 2002 Dec; 29(12):2666-7. PubMed ID: 12465176
[No Abstract] [Full Text] [Related]
2. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.
Endo H; Hosono T; Kondo H
J Rheumatol; 1994 May; 21(5):864-70. PubMed ID: 8064727
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibodies in patients with systemic sclerosis.
Manolova I; Dancheva M
J Rheumatol; 2003 Sep; 30(9):2078-9; author reply 2079-80. PubMed ID: 12966621
[No Abstract] [Full Text] [Related]
4. Antineutrophil cytoplasmic autoantibodies in systemic sclerosis with renal failure.
Huong DL; Papo T; Gatfosse M; Frances C; Godeau P; Beaufils H
J Rheumatol; 1995 Apr; 22(4):791-2. PubMed ID: 7791189
[No Abstract] [Full Text] [Related]
5. Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum.
Herrera-Esparza R; Aguilar JL; Saucedo A; González I; López-Robles E; Avalos-Díaz E
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):617-20. PubMed ID: 16164722
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
Khanna D; Aggarwal A; Bhakuni DS; Dayal R; Misra R
J Rheumatol; 2003 Jun; 30(6):1248-52. PubMed ID: 12784398
[TBL] [Abstract][Full Text] [Related]
7. [Antineutrophil cytoplasmic antibodies and associated diseases].
Sghiri R; Meddeb H; Bouguila J; Jarray M; Bahri F; Nouira R; Zellama D; Achour A; Essoussi AS; Harbi A; Ghedira I
Pathol Biol (Paris); 2009 Jul; 57(5):398-402. PubMed ID: 18834675
[TBL] [Abstract][Full Text] [Related]
8. Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy.
Villaverde V; Balsa A; Cabezas JA; Fernández-Prada M; Torre A; Mola EM
Rheumatology (Oxford); 1999 Feb; 38(2):190-1. PubMed ID: 10342639
[No Abstract] [Full Text] [Related]
9. Safety of intravenous methylprednisolone therapy in patients suffering from systemic sclerosis.
Vanthuyne M; Depresseux G; Houssiau FA
Scand J Rheumatol; 2010 Mar; 39(2):178-9. PubMed ID: 20038263
[No Abstract] [Full Text] [Related]
10. Clinical relevance of antineutrophil cytoplasmic antibodies in Algerian scleroderma patients.
Tahiat A; Djidjik R; Abdessmed A; Mellal Y; Nebbab A; Gharnaout M; Ghaffor M; Ladjouze A
Joint Bone Spine; 2013 Oct; 80(5):547-8. PubMed ID: 23541846
[No Abstract] [Full Text] [Related]
11. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis.
Kamen DL; Wigley FM; Brown AN
J Rheumatol; 2006 Sep; 33(9):1886-8. PubMed ID: 16832842
[TBL] [Abstract][Full Text] [Related]
12. [Renal involvement in progressive systemic sclerosis (scleroderma). Anatomo-clinical study of 7 cases].
Surian M; Antonacci A; Rovati C; Civati G; Colussi G; Minola E; Barbiano di Belgiojoso G; Minetti L
Minerva Nefrol; 1980; 27(2):333-42. PubMed ID: 7219855
[No Abstract] [Full Text] [Related]
13. Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis.
Carvajal I; Bernis C; Sanz P; Garcia A; Garcia-Vadillo A; Traver JA
Nephrol Dial Transplant; 1997 Mar; 12(3):576-7. PubMed ID: 9075145
[No Abstract] [Full Text] [Related]
14. Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis.
Grypiotis P; Cozzi F; Ruffatti A
J Rheumatol; 2004 Jul; 31(7):1468-9. PubMed ID: 15229985
[No Abstract] [Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies in systemic sclerosis.
Kiraz S; Simsek H; Ertenli I; Benekli M; Kadayifci A
Clin Rheumatol; 1996 Sep; 15(5):519-20. PubMed ID: 8894374
[No Abstract] [Full Text] [Related]
16. [Renal crisis at the onset of systemic sclerosis].
Horn HC; Otte KE; Jensen JE
Ugeskr Laeger; 2003 Sep; 165(40):3832. PubMed ID: 14560507
[No Abstract] [Full Text] [Related]
17. Association of ANCA-positive vasculitis with thyroid disease.
Rothe HM; Siegmund J; Müller H; Wopperer J
Nephrol Dial Transplant; 2008 Jun; 23(6):2107; author reply 2107-8. PubMed ID: 18323519
[No Abstract] [Full Text] [Related]
18. [Systemic scleroderma associated to a glomerulonephritis with anti-MPO antibodies: a case report and literature review].
Sol EB; Bonkain F; Vande Houtte K; Dratwa M
Rev Med Brux; 2008; 29(6):559-67. PubMed ID: 19202712
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules.
Chen M; Zhao MH; Zhang YK; Wang HY
Nephrology (Carlton); 2005 Oct; 10(5):491-5. PubMed ID: 16221101
[TBL] [Abstract][Full Text] [Related]
20. Increased serum levels of soluble triggering receptor expressed on myeloid cells-1 in antineutrophil cytoplasmic antibody-associated vasculitis.
Daikeler T; Regenass S; Tyndall A; Gencay MM; Roth M; Christ-Crain M; Müller B; Hess C
Ann Rheum Dis; 2008 May; 67(5):723-4. PubMed ID: 18408110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
